Showing results (61-70 of 282) with videos related to
Sort By:
Pageof 29
Annals of the New York Academy of Sciences|January 22, 2005
GATA-1: friends, brothers, and coworkersFranck Morceau, Michael Schnekenburger, Mario Dicato, et al.International Journal of Cell Biology|June 14, 2013
Natural compounds as regulators of the cancer cell metabolismClaudia Cerella, Flavia Radogna, Mario Dicato, et al.Pharmacological Research|November 15, 2017
Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathwaysManon Lernoux, Michael Schnekenburger, Mario Dicato, et al.Molecules (Basel, Switzerland)|November 26, 2016
Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in CancerHélène Losson, Michael Schnekenburger, Mario Dicato, et al.Genes & Nutrition|February 14, 2012
Histone deacetylase modulators provided by Mother NatureCarole Seidel, Michael Schnekenburger, Mario Dicato, et al.Current Topics in Medicinal Chemistry|August 26, 2015
Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatmentsMichael Schnekenburger, Cristina Florean, Mario Dicato, et al.Methods in Molecular Biology (Clifton, N.J.)|June 1, 2021
Assessment of Mitochondrial Cell Metabolism by Respiratory Chain Electron Flow AssaysFlavia Radogna, Déborah Gérard, Mario Dicato, et al.Cancers|February 5, 2020
HDAC6-an Emerging Target Against Chronic Myeloid Leukemia?Hélène Losson, Michael Schnekenburger, Mario Dicato, et al.Current Drug Targets|February 3, 2015
Roles of Apoptosis and Cellular Senescence in Cancer and AgingClaudia Cerella, Cindy Grandjenette, Mario Dicato, et al.Epigenomics|February 18, 2015
Histone deacetylase 6 in health and diseaseCarole Seidel, Michael Schnekenburger, Mario Dicato, et al.Pageof 29